Severe cutaneous adverse drug reactions due to antituberculosis drugs and their management
Metin Keren, Aysun Aynaci, Ismet Bulut, Neslihan Cerrah Demir, Aylin Babalik, Ali Selcuk · 2025
Read Severe cutaneous adverse drug reactions due to antituberculosis drugs and their management by Metin Keren, Aysun Aynaci, Ismet Bulut, Neslihan Cerrah Demir, Aylin Babalik, Ali Selcuk (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821122.txt.
Description
Metin Keren and co-authors report severe skin reactions to tuberculosis drugs in a 2025 study. The same drugs that cure tuberculosis can trigger life threatening rashes and blistering. The team reviewed a decade of ward records at a referral hospital: 4,039 tuberculosis patients in all. Of those, 316, about eight percent, developed drug reactions that reached the allergy clinic.
The paper presents which severe reactions occurred and how each was managed. Stopping the culprit drug while keeping tuberculosis covered is a tightrope. A large real life series gives treating teams a playbook: which drug to suspect, what to substitute, and when rechallenge is safe. Such guidance is scarce for this exact dilemma.
Catalog record
| CREATOR | Metin Keren, Aysun Aynaci, Ismet Bulut, Neslihan Cerrah Demir, Aylin Babalik, Ali Selcuk |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |